Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · IEX Real-Time Price · USD
1.510
+0.060 (4.14%)
Jul 22, 2024, 10:01 AM EDT - Market open
Unity Biotechnology Employees
Unity Biotechnology had 19 employees as of December 31, 2023. The number of employees decreased by 13 or -40.63% compared to the previous year.
Employees
19
Change (1Y)
-13
Growth (1Y)
-40.63%
Revenue / Employee
n/a
Profits / Employee
-$1,830,632
Market Cap
25.02M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Meihua International Medical Technologies Co. | 617 |
Trinity Biotech | 380 |
Accelerate Diagnostics | 134 |
Femasys | 34 |
CytoMed Therapeutics | 28 |
NeuroOne Medical Technologies | 16 |
Akso Health Group | 12 |
Cocrystal Pharma | 12 |
UBX News
- 2 hours ago - UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer - GlobeNewsWire
- 2 months ago - UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 3 months ago - UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting - GlobeNewsWire
- 3 months ago - UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME - GlobeNewsWire
- 3 months ago - UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 5 months ago - New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss - GlobeNewsWire
- 7 months ago - UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME - GlobeNewsWire
- 8 months ago - UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates - GlobeNewsWire